nigericin has been researched along with Neoplasm Metastasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bei, JX; Chen, LZ; Deng, CC; Feng, FT; Feng, QS; Hu, WR; Liang, Y; Wu, MS; Zeng, YX | 1 |
| Dong, TT; Fan, XK; Feng, B; Wang, LL; Zhao, HC; Zheng, MH; Zhou, HM | 1 |
2 other study(ies) available for nigericin and Neoplasm Metastasis
| Article | Year |
|---|---|
Nigericin selectively targets cancer stem cells in nasopharyngeal carcinoma.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cell Line, Tumor; Cell Movement; Cisplatin; Down-Regulation; Drug Synergism; Humans; Immunohistochemistry; Mice; Mice, Nude; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Neoplastic Stem Cells; Nigericin; Polycomb Repressive Complex 1; Random Allocation; Xenograft Model Antitumor Assays | 2013 |
Suppression of colorectal cancer metastasis by nigericin through inhibition of epithelial-mesenchymal transition.
Topics: AC133 Antigen; Anti-Bacterial Agents; Antigens, CD; Cadherins; Cell Line, Tumor; Cell Movement; Cell Survival; Colorectal Neoplasms; Epithelial-Mesenchymal Transition; Flow Cytometry; Gene Expression Regulation, Neoplastic; Glycoproteins; Humans; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplastic Stem Cells; Nigericin; Organoplatinum Compounds; Oxaliplatin; Peptides; Vimentin | 2012 |